All In Biotech

Free tool

FAERS Monitor: Cambia

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022165 or its brand name (Cambia, Diclofenac Potassium). Reports on generic versions are filed under their own applications.

Reports

10,696

Serious

8,489

79% of reports

Hospitalization

4,891

Death reported

4,383

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective2,897
  • rheumatoid arthritis2,674
  • fatigue2,642
  • off label use2,597
  • pain2,541
  • rash2,540
  • systemic lupus erythematosus2,494
  • joint swelling2,437
  • wound2,383
  • pemphigus2,317
  • glossodynia2,295
  • synovitis2,293
  • infusion related reaction2,269
  • hand deformity2,260
  • abdominal discomfort2,259

Reports by year received

View as table
YearReports
20044
20059
200659
20079
200816
200914
201015
201166
201245
201354
201471
2015205
2016894
2017511
2018486
2019642
2020597
2021499
2022689
2023845
20242,081
20251,931
2026954

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,463 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pemphigusSignal2,317447.0429.1840,382
hand deformitySignal2,260409.0392.6761,728
synovitisSignal2,293286.3275.2569,338
glossodyniaSignal2,295224.5215.9458,620
woundSignal2,383183.2176.4395,322
systemic lupus erythematosusSignal2,494148.5143.3340,248
infusion related reactionSignal2,26969.767.1148,704
rheumatoid arthritisSignal2,67447.445.9119,216
joint swellingSignal2,43740.539.192,475
abdominal discomfortSignal2,25926.825.955,836
rashSignal2,54011.511.124,761
painSignal2,5418.27.916,379
fatigueSignal2,6426.76.513,233
off label useSignal2,5975.85.710,849
drug ineffectiveSignal2,8974.34.27,894

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.